O
NKTX icon

OrbiMed’s Nkarta NKTX Stock Holding History

OrbiMed’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-821,400
Closed -$1.51M – 112
2025
Q1 		$1.51M Hold
821,400
– – 0.04% 96
2024
Q4 		$2.05M Sell
821,400
-659,200
-45% -$2.03M 0.04% 101
2024
Q3 		$6.69M Buy
1,480,600
+680,600
+85% +$3.87M 0.12% 88
2024
Q2 		$4.73M Hold
800,000
– – 0.09% 91
2024
Q1 		$8.65M Buy
+800,000
New +$8.32M 0.16% 85

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return